Page last updated: 2024-10-30

meprobamate and Diabetes Mellitus

meprobamate has been researched along with Diabetes Mellitus in 2 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowd, JE1
Glasunov, IS1
Jaksić, Z1
Kesić, B1
Ray, D1
Steinberger, C1
Stromberg, J1
Vuletić, S1
Hofmann, KW1
Manach, J1
Sögtrop, HH1

Reviews

1 review available for meprobamate and Diabetes Mellitus

ArticleYear
[Dipotassium chlorazepate. Clinical reports on a new anxiolytic].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:1

    Topics: Adult; Aged; Alcoholism; Automobile Driving; Cardiovascular Diseases; Diabetes Mellitus; Diazepam; D

1970

Other Studies

1 other study available for meprobamate and Diabetes Mellitus

ArticleYear
Design and methodology of the Zagreb preliminary study: response rates at the study stages.
    Cor et vasa, 1976, Volume: 18, Issue:4

    Topics: Cardiovascular Diseases; Diabetes Mellitus; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperte

1976